Evidence map›Paper›PMID 40052541›Full record

ArticleJournal of medical microbiology2025

Impact of the COVID-19 pandemic on invasive pneumococcal disease in American Indian communities in the Southwest US.

Catherine G Sutcliffe, Shea Littlepage, Del Yazzie, George Brasinikas, Loretta Christensen, Shawnell Damon, Estar Denny, Sheri L Dixon, Lindsay R Grant, Marcella Harker-Jones and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Catherine G SutcliffeCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Shea LittlepageCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Del YazzieNavajo Epidemiology Center, Window Rock, Arizona, USA.
George BrasinikasGallup Indian Medical Center, Indian Health Service, Gallup, New Mexico, USA.
Loretta ChristensenIndian Health Service, Rockville, MD, USA.
Shawnell DamonNavajo Area Indian Health Service, Window Rock, Arizona, USA.
Estar DennyCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sheri L DixonTséhootsooí Medical Center, Fort Defiance, Arizona, USA.
Lindsay R GrantCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Marcella Harker-JonesArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
James McAuleyWhiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona, USA.
Pierrette MontanezNorthern Navajo Medical Center, Indian Health Service, Shiprock, New Mexico, USA.
Dennie ParkerCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Alisa ReasonoverArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Amy RiceCrownpoint Health Care Facility, Indian Health Service, Crownpoint, New Mexico, USA.
Kristen RoesslerCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Eugene RomancitoWhiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona, USA.
Charis SalabyeTuba City Regional Health Care Corporation, Tuba City, Arizona, USA.
Victoria M SergentCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Brenna Simons-PetrusaArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Valerie TenequerKayenta Health Center, Kayenta, Arizona, USA.
Polly ThompsonChinle Comprehensive Health Care Facility, Indian Health Service, Chinle, Arizona, USA.
Minnie TsingineWinslow Indian Health Care Center, Winslow, Arizona, USA.
Robert C WeatherholtzCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Laura L HammittCenter for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

American Indian (AI) communities in the Southwest have a high burden of invasive pneumococcal disease (IPD) and COVID-19. Through laboratory-based surveillance, the impact of the pandemic on IPD incidence and serotype distribution was evaluated in two AI communities. IPD rates were lower during the pandemic (21.8 vs. 39.0/100 000 pre-pandemic). Rates increased in 2021 compared to 2020 but not to pre-pandemic levels. Cases with SARS-CoV-2 co-infection had a higher case fatality rate (45.2% vs. 17.6% without co-infection). No significant change in serotype distribution was observed. Continued surveillance in these communities is critical to understand the changing IPD burden as the pandemic evolves.

Indexed as

COVID-19Pneumococcal InfectionsAdolescentAdultAgedChildChild, PreschoolCoinfectionFemaleHumansIncidenceMaleMiddle AgedPandemicsSARS-CoV-2SerogroupCOVID-19Indigenous healthinvasive pneumococcal diseasesurveillance

Identifiers

PMID40052541
PMCPMC12282234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.